The Psychological Impact of Melasma on Patients Attending a Tertiary Care Health Facility in Pakistan; A Cross Sectional Study
DOI:
https://doi.org/10.70749/ijbr.v3i4.1062Keywords:
Melasma, Psychological Impact, DASS-21, Duration of MelasmaAbstract
Objective: This study aims to assess the psychological impact of melasma on patients visiting a tertiary care hospital in Pakistan using DASS-21 scale. Methodology: A cross sectional study was done at Dermatology department, Pak Emirates Military Hospital, Rawalpindi (over the total duration of 6 months (July to Dec, 2024). A total of 392 patients visiting dermatology OPD of Pak Emirates Military Hospital, Rawalpindi were selected via non-probability consecutive sampling technique. Psychological impact of melasma was assessed via a self-reporting questionnaire DASS-21 using Depression, Anxiety and Stress as primary outcomes. Results: The scale identified depression among 22% patients with mean score of 20.5 + 4.3, while rest of patients exhibit no or very little sign of depression. Anxiety was observed in 28% patients with mean score of 16.2 + 3.8, and stress was reported in 37% of patients with mean score of 22.7 + 4.9. Correlation between mean DASS-21 score of patients and duration of disease was found significant. Conclusion: Melasma patients experience significant impairment on quality of life. These symptoms appear to be related with duration of melasma. It is essential for health care providers to acknowledge and evaluate the psychological impact of melasma when counselling and treating the patients.
Downloads
References
Abdalla, M. A. (2021). Melasma clinical features, diagnosis, epidemiology and etiology: An update review. Siriraj Medical Journal, 73(12), 841-850. https://doi.org/10.33192/smj.2021.109
Ogbechie-Godec, O. A., & Elbuluk, N. (2017). Melasma: An up-to-Date comprehensive review. Dermatology and Therapy, 7(3), 305-318. https://doi.org/10.1007/s13555-017-0194-1
Handel, A. C., Miot, L. D., & Miot, H. A. (2014). Melasma: A clinical and epidemiological review. Anais Brasileiros de Dermatologia, 89(5), 771-782. https://doi.org/10.1590/abd1806-4841.20143063
Al-Hamdi, K., J. Hasony, H., & L. Jareh, H. (2008). Melasma in basrah: A clinical and epidemiological study. The Medical Journal of Basrah University, 26(1), 1-5. https://doi.org/10.33762/mjbu.2008.48322
Handel, A. C., Miot, L. D., & Miot, H. A. (2014). Melasma: A clinical and epidemiological review. Anais Brasileiros de Dermatologia, 89(5), 771-782. https://doi.org/10.1590/abd1806-4841.20143063
Rahman, A., Basit, A., Mohsin, S., Ahmed, N., Tahir, M., & Ishfaq, A. (2022). Quality of life of Melasma patients in Pakistan. Pakistan Armed Forces Medical Journal, 72(1), 307-10. https://doi.org/10.51253/pafmj.v72i1.7401
Sarkar, R., Arora, P., Garg, V. K., Sonthalia, S., & Gokhale, N. (2014). Melasma update. Indian dermatology online journal, 5(4), 426-435. https://doi.org/10.4103/2229-5178.142484
Kaleem, S., Ghafoor, R., & Khan, S. (2020). Comparison of efficacy of Tranexamic acid Mesotherapy versus 0.9% normal saline for Melasma; A split face study in a tertiary care hospital of Karachi. Pakistan Journal of Medical Sciences, 36(5). https://doi.org/10.12669/pjms.36.5.2379
McKesey, J., Tovar-Garza, A., & Pandya, A. G. (2019). Melasma treatment: An evidence-based review. American Journal of Clinical Dermatology, 21(2), 173-225. https://doi.org/10.1007/s40257-019-00488-w
Zhu, Y., Zeng, X., Ying, J., Cai, Y., Qiu, Y., & Xiang, W. (2022). Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis. PLOS ONE, 17(1), e0262833. https://doi.org/10.1371/journal.pone.0262833
Shaukat, S., Aman, S., Hussain, I., & Kazmi, A. H. (2013). The effect of oral doxycycline and topical 5% benzoyl peroxide on quality of life in patients with mild to moderate acne vulgaris. Journal of Pakistan Association of Dermatologists, 23(2), 173-179. https://www.jpad.com.pk/index.php/jpad/article/view/303
Balkrishnan, R., Mcmichael, A., Camacho, F., Saltzberg, F., Housman, T., Grummer, S., Feldman, S., & Chren, M. (2003). Development and validation of a health-related quality of life instrument for women with melasma. British Journal of Dermatology, 149(3), 572-577. https://doi.org/10.1046/j.1365-2133.2003.05419.x
Ali, A. M., Alkhamees, A. A., Hori, H., Kim, Y., & Kunugi, H. (2021). The depression anxiety stress scale 21: Development and validation of the depression anxiety stress scale 8-Item in psychiatric patients and the general public for easier mental health measurement in a post COVID-19 world. International Journal of Environmental Research and Public Health, 18(19), 10142. https://doi.org/10.3390/ijerph181910142
Armenta, A. M., Henkel, E. D., & Ahmed, A. M. (2019). Pigmentation disorders in the elderly. Drugs & Aging, 36(3), 235-245. https://doi.org/10.1007/s40266-018-00633-w
Freitag, F., Cestari, T., Leopoldo, L., Paludo, P., & Boza, J. (2008). Effect of melasma on quality of life in a sample of women living in southern Brazil. Journal of the European Academy of Dermatology and Venereology, 22(6), 655-662. https://doi.org/10.1111/j.1468-3083.2007.02472.x
Amatya, B., & Pokhrel, D. B. (2019). Assessment and Comparison of Quality of Life in Patients with Melasma and Vitiligo. PubMed, 17(66), 114–118.
Paudel, S., Acharya Poudel, I., Upadhyay, P., Kumar Shah, M., Pokharel, S., & Sharma, R. (2022). Quality of life in Nepalese patients with Melasma: An observational cross-sectional study at a tertiary center. Journal of Nepal Health Research Council, 20(02), 316-320. https://doi.org/10.33314/jnhrc.v20i02.3875
Parać, E., & Bukvić Mokos, Z. (2024). Unmasking Melasma: Confronting the treatment challenges. Cosmetics, 11(4), 143. https://doi.org/10.3390/cosmetics11040143
Balkrishnan, R., Mcmichael, A., Camacho, F., Saltzberg, F., Housman, T., Grummer, S., Feldman, S., & Chren, M. (2003). Development and validation of a health-related quality of life instrument for women with melasma. British Journal of Dermatology, 149(3), 572-577. https://doi.org/10.1046/j.1365-2133.2003.05419.x
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
